communicating benefit and risk information
Published 11 years ago • 5K plays • Length 4:16Download video MP4
Download video MP3
Similar videos
-
4:58
communicating drug safety messages
-
24:25
application of risk management principles for medical devices
-
3:53
fda drug info rounds, november 2012: drug safety communications
-
41:06
division of risk management: overview of review activities and rems - pharmacovigilance 2020
-
23:18
risk basics for medical devices
-
7:31:31
fda regulatory education for industry (redi) – devices track
-
33:18
investigational new drug (ind) submission: content/format and first 30 days (5of14) redi 2018
-
7:38
how does the fda approve a drug?
-
2:28
what is fda’s role in regulating drugs?
-
31:21
benefit-risk considerations in drug development (6/14) redi 2017
-
0:58
wi-007 fda estar v5.3 cybersecurity requirements webinar ( oct. 24)
-
48:50
advancing transparency and regulatory science activities on risk evaluation and mitigation strategy
-
4:55
10 facts about what fda does and does not approve #fdafacts (1-10)
-
57:37
risk evaluation and mitigation strategies (rems) compliance program
-
5:05
efsa explains risk assessment of food and feed risk
-
40:26
benefit-risk considerations during drug product development (8of14) redi 2018
-
35:54
fda's role in improving nutrition: labeling and other authorities
-
56:41
postmarket safety surveillance: tools, methods, and benefit-risk framework - pharmacovigilance 2020
-
0:45
with #foodrecalls on the rise, here's how to protect yourself. #health #fda
-
0:33
get the facts on chemicals in foods with the u.s. food and drug administration
-
4:22:46
integrated assessment of marketing applications and integrated review documentation workshop